Translational Model‐Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Translational Model‐Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development

Published:2020-04-02 Issue:2 Volume:108 Page:274-286
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Susanto Budi O.¹,Wicha Sebastian G.²,Hu Yanmin³,Coates Anthony R.M.³,Simonsson Ulrika S.H.¹

Affiliation:

1. Department of Pharmaceutical Biosciences Uppsala University Uppsala Sweden

2. Department of Clinical Pharmacy Institute of Pharmacy University of Hamburg Hamburg Germany

3. Institute for Infection and Immunity St. George’s University of London London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1814

Reference40 articles.

1. The early bactericidal activity of drugs in patients with pulmonary tuberculosis;Jindani A.;Am. Rev. Respir. Dis.,1980

2. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

3. Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

4. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions

5. A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effectsin vitro

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and development;European Respiratory Journal;2023-08

2. Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium;iScience;2023-04

3. Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development;Frontiers in Pharmacology;2023-03-14

4. Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study;Antibiotics;2023-02-05

5. In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III;International Journal of Molecular Sciences;2023-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3